pharmaceutical investing Scilex Announces Pricing and Availability of ZTlido for the Commercial Launch of its First Product in October of 2018
pharmaceutical investing Sorrento Therapeutics Subsidiary, Scilex, Raises $140 million in Non-Dilutive Royalty-Based Financing
LaFleur Minerals Closes $1.66 Million Flow-Through Offering to Advance Drilling and PEA-Related Work at its Swanson Gold Deposit
